Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IOLG (AA 1-344) antibody (FITC)

This Rabbit Polyclonal antibody specifically detects IOLG . It exhibits reactivity toward Bacillus subtilis.
Catalog No. ABIN7140677
$351.92
Plus shipping costs $50.00
Shipping to: United States
Delivery in 13 to 17 Business Days

Quick Overview for IOLG (AA 1-344) antibody (FITC) (ABIN7140677)

Target

IOLG

Reactivity

  • 4
  • 4
Bacillus subtilis

Host

  • 8
Rabbit

Clonality

  • 8
Polyclonal

Conjugate

  • 2
  • 2
  • 2
  • 2
FITC

Application

Please inquire
  • Binding Specificity

    AA 1-344

    Purpose

    iolG Antibody, FITC conjugated

    Cross-Reactivity

    Bacillus subtilis

    Purification

    Protein G purified

    Purity

    >95 %

    Immunogen

    Recombinant Bacillus subtilis Inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase protein (1-344AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    IOLG

    Background

    Background: Involved in the oxidation of myo-inositol (MI) and D-chiro-inositol (DCI) to 2-keto-myo-inositol (2KMI or 2-inosose) and 1-keto-D-chiro-inositol (1KDCI), respectively. Can also use D-glucose and D-xylose, and shows a trace of activity with D-ribose and D-fructose.

    Aliases: iolG antibody, idh antibody, BSU39700 antibody, E83GInositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase antibody, EC 1.1.1.18 antibody, EC 1.1.1.369 antibody, Myo-inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase antibody, MI 2-dehydrogenase/DCI 3-dehydrogenase antibody

    UniProt

    P26935
You are here:
Chat with us!